tiprankstipranks
Trending News
More News >
Memphasys Ltd (AU:MEM)
ASX:MEM
Advertisement

Memphasys Ltd (MEM) Price & Analysis

Compare
7 Followers

MEM Stock Chart & Stats


Memphasys Ltd News

MEM FAQ

What was Memphasys Ltd’s price range in the past 12 months?
Memphasys Ltd lowest share price was <AU$0.01 and its highest was AU$0.01 in the past 12 months.
    What is Memphasys Ltd’s market cap?
    Memphasys Ltd’s market cap is AU$8.93M.
      When is Memphasys Ltd’s upcoming earnings report date?
      Memphasys Ltd’s upcoming earnings report date is Feb 20, 2026 which is in 154 days.
        How were Memphasys Ltd’s earnings last quarter?
        Memphasys Ltd released its earnings results on Aug 28, 2025. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
          Is Memphasys Ltd overvalued?
          According to Wall Street analysts Memphasys Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Memphasys Ltd pay dividends?
            Memphasys Ltd does not currently pay dividends.
            What is Memphasys Ltd’s EPS estimate?
            Memphasys Ltd’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Memphasys Ltd have?
            Memphasys Ltd has 1,983,598,100 shares outstanding.
              What happened to Memphasys Ltd’s price movement after its last earnings report?
              Memphasys Ltd reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Memphasys Ltd?
                Currently, no hedge funds are holding shares in AU:MEM

                Memphasys Ltd Stock Smart Score

                4
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Fundamentals

                Return on Equity
                -80.98%
                Trailing 12-Months
                Asset Growth
                -11.33%
                Trailing 12-Months

                Company Description

                Memphasys Ltd

                Memphasys Ltd (MEM) is an Australian-based biotechnology company focused on developing and commercializing advanced reproductive technologies. The company primarily operates in the fertility sector, offering innovative solutions designed to enhance assisted reproductive outcomes. Memphasys's flagship product, Felix, is a novel device aimed at improving the quality of sperm used in IVF treatments by selecting the healthiest sperm cells through a unique separation process.

                Memphasys Ltd (MEM) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Living Cell Technologies
                Regeneus Ltd.
                Avecho Biotechnology Limited
                AdAlta Ltd.
                Chimeric Therapeutics Ltd.
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis